His lab is focusing on refining the alanine-scanning assay to a couple essential residues that will accurately distinguish between fibrils from neurodegenerative tauopathies. He envisions utilizing this streamlined assay for postmortem neuropathological analysis, And perhaps for blood screening of tauopathies.The factors that establish whether an a